Cargando…
Leveraging the power of pooled data for cancer outcomes research
BACKGROUND: Clinical trials continue to be the gold standard for determining the efficacy of novel cancer treatments, but they may also expose participants to the potential risks of unpredictable or severe toxicities. The development of validated tools that better inform patients of the benefits and...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4971686/ https://www.ncbi.nlm.nih.gov/pubmed/27484162 http://dx.doi.org/10.1186/s40880-016-0132-0 |